The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...
Already a monolith in the clinical testing space, Labcorp is aiming to further swell its testing capabilities with the acquisition of contract research organization Toxikon. The CRO provides ...
“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp ...
Laboratory Corporation of America Holdings or LabCorp LH continues to remain in the headlines with major back-to-back developments within the company’s business. Following last week’s announcement of ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test ...
While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the ...
BURLINGTON, N.C.--(BUSINESS WIRE)--For the millions of people in the United States living with an advanced form of chronic liver disease, simply understanding the potential for future complications ...
RESEARCH TRIANGLE PARK – Burlington-based Labcorp has begun selling the first widely accessible test for direct evidence of neurodegeneration and neuronal injury. The new Neurofilament Light Chain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results